← Mechanisms of action
Dystrophin pre-mRNA
NUCLEIC-ACIDHomo sapiens
Drugs acting on this target (26)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| golodirsen (Vyondys 53) | Activator | approved | Gene therapy | Dystrophin pre-mRNA activator |
| drisapersen | Antisense inhibitor | experimental | Nucleic acid | Dystrophin pre-mRNA antisense inhibitor |
| ns-050/ncnp-03 | Antisense inhibitor | experimental | Nucleic acid | Dystrophin pre-mRNA antisense inhibitor |
| pro053 | Antisense inhibitor | experimental | Nucleic acid | Dystrophin pre-mRNA antisense inhibitor |
| scaav9.u7.acca | Antisense inhibitor | experimental | Gene therapy | Dystrophin pre-mRNA antisense inhibitor |
| viltolarsen (Viltepso) | Antisense inhibitor | approved | Nucleic acid | Dystrophin pre-mRNA antisense inhibitor |
| wve-n531 | Antisense inhibitor | experimental | Nucleic acid | Dystrophin pre-mRNA antisense inhibitor |
| eteplirsen (Exondys 51) | Modulator | approved | Nucleic acid | Dystrophin pre-mRNA modulator |
| drisapersen | Other | experimental | Nucleic acid | Dystrophin pre-mRNA other |
| casimersen (Amondys 45) | Positive modulator | approved | Gene therapy | Dystrophin pre-mRNA positive modulator |
| drisapersen | Positive modulator | experimental | Nucleic acid | Dystrophin pre-mRNA positive modulator |
| eteplirsen (Exondys 51) | Positive modulator | approved | Nucleic acid | Dystrophin pre-mRNA positive modulator |
| golodirsen (Vyondys 53) | Positive modulator | approved | Gene therapy | Dystrophin pre-mRNA positive modulator |
| viltolarsen (Viltepso) | Positive modulator | approved | Nucleic acid | Dystrophin pre-mRNA positive modulator |
| aoc 1044 | Supplementation | experimental | Gene therapy | Dystrophin pre-mRNA supplementation |
| crd-tmh-001 | Supplementation | experimental | Gene therapy | Dystrophin pre-mRNA supplementation |
| delandistrogene moxeparvovec (ELEVIDYS) | Supplementation | approved | Gene therapy | Dystrophin pre-mRNA supplementation |
| fordadistrogene movaparvovec | Supplementation | experimental | Gene therapy | Dystrophin pre-mRNA supplementation |
| jwk007 | Supplementation | experimental | Gene therapy | Dystrophin pre-mRNA supplementation |
| pgn-edo51 | Supplementation | experimental | Gene therapy | Dystrophin pre-mRNA supplementation |
| raav2.5-cmv-minidystrophin | Supplementation | experimental | Gene therapy | Dystrophin pre-mRNA supplementation |
| raavrh74.mck.micro-dystrophin | Supplementation | experimental | Gene therapy | Dystrophin pre-mRNA supplementation |
| rgx-202 | Supplementation | experimental | Gene therapy | Dystrophin pre-mRNA supplementation |
| sgt-001 | Supplementation | experimental | Gene therapy | Dystrophin pre-mRNA supplementation |
| sgt-003 | Supplementation | experimental | Gene therapy | Dystrophin pre-mRNA supplementation |
| sqy51 | Supplementation | experimental | Gene therapy | Dystrophin pre-mRNA supplementation |